| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (1023 + methicillin-susceptible) |
- |
- |
31.3 － ? |
SB1  |
138 |
| Staphylococcus aureus (10287 + methicillin-resistant + ESBL) |
- |
- |
>32 － ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
1055 |
| Staphylococcus aureus (10287 + methicillin-resistant + ESBL) |
- |
- |
>256 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1055 |
| Staphylococcus aureus (1029 + methicillin-resistant) |
- |
- |
2 － ? |
Meticillin (Methicillin, Staphcillin) |
138 |
| Staphylococcus aureus (1029 + methicillin-resistant) |
- |
- |
125 － ? |
Luteolin |
138 |
| Staphylococcus aureus (1029 + methicillin-susceptible) |
- |
- |
0.5 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
138 |
| Staphylococcus aureus (1029 + methicillin-susceptible) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
138 |
| Staphylococcus aureus (1029 + methicillin-susceptible) |
- |
- |
3.9 － ? |
Apigenin |
138 |
| Staphylococcus aureus (1029 + methicillin-susceptible) |
- |
- |
7.8 － ? |
SB1 |
138 |
| Staphylococcus aureus (103-17 (grl(A)[S80F] grl(A)[E84V] gyr(A)[S84L]) + CAMHB + pH 5.8) |
- |
- |
4 － ? |
Finafloxacin |
1045 |
| Staphylococcus aureus (103-17 (grl(A)[S80F] grl(A)[E84V] gyr(A)[S84L]) + CAMHB + pH 5.8) |
- |
- |
128 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1045 |
| Staphylococcus aureus (103-17 (grl(A)[S80F] grl(A)[E84V] gyr(A)[S84L]) + CAMHB + pH 7.2) |
- |
- |
8 － ? |
Finafloxacin |
1045 |
| Staphylococcus aureus (103-17 (grl(A)[S80F] grl(A)[E84V] gyr(A)[S84L]) + CAMHB + pH 7.2) |
- |
- |
64 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1045 |
| Staphylococcus aureus (1032 + methicillin-resistant) |
- |
- |
2 － ? |
Meticillin (Methicillin, Staphcillin) |
138 |
| Staphylococcus aureus (1032 + methicillin-resistant) |
- |
- |
125 － ? |
Luteolin |
138 |
| Staphylococcus aureus (1032 + methicillin-susceptible) |
- |
- |
0.12 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
138 |
| Staphylococcus aureus (1032 + methicillin-susceptible) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
138 |
| Staphylococcus aureus (1032 + methicillin-susceptible) |
- |
- |
15.6 － ? |
Apigenin |
138 |
| Staphylococcus aureus (1032 + methicillin-susceptible) |
- |
- |
15.6 － ? |
SB1 |
138 |
| Staphylococcus aureus (10389) |
- |
- |
0.015 － ? |
Rifampicin (Rifampin) |
231 |
| Staphylococcus aureus (10389) |
- |
- |
0.12 － ? |
Fusidic acid (Fucidin) |
231 |
| Staphylococcus aureus (10389) |
- |
- |
0.25 － ? |
Gentamicin (Gentamycin, Garamycin) |
231 |
| Staphylococcus aureus (10389) |
- |
- |
0.5 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
231 |
| Staphylococcus aureus (10389) |
- |
- |
1 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
231 |
| Staphylococcus aureus (10389) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
231 |
| Staphylococcus aureus (10391) |
- |
- |
0.015 － ? |
Rifampicin (Rifampin) |
231 |
| Staphylococcus aureus (10391) |
- |
- |
0.25 － ? |
Gentamicin (Gentamycin, Garamycin) |
231 |
| Staphylococcus aureus (10391) |
- |
- |
0.5 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
231 |